Comparative genomic hybridization of low-grade central osteosarcoma

M. Tarkkanen, T. Böhling, G. Gamberi, P. Ragazzini, M. S. Benassi, A. Kivioja, P. Kallio, I. Elomaa, P. Picci, S. Knuutila

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Very little is known concerning the cytogenetic and molecular genetic changes of low-grade central osteosarcoma, a rare form of osteosarcoma. In the present study, we used comparative genomic hybridization (CGH) to screen for DNA sequence copy number aberrations in 10 samples from 6 patients: 7 typical low-grade central osteosarcomas, one low-grade (Grade II) central osteosarcoma, and two high-grade (III and IV) local recurrences of a low- grade central osteosarcoma. Nine samples had aberrations. Six typical low- grade central osteosarcoma samples had a single DNA sequence copy number change per tumor. Three samples from more advanced tumors (a Grade II low- grade central osteosarcoma and local recurrences of Grade III and IV) had a mean of five changes per tumor. Recurrent changes affected these minimal common regions: +12q13-q14 (three tumors), +12p (two tumors), and +6p21.1- p21.3 (two tumors). Nine samples were analyzed for CDK4 and MDM2 expression and SAS amplification. One sample with a gain of chromosome 12 had a very strong expression of MDM2, strong expression of CDK4, and amplification of SAS. One sample with a gain of 12q13-q14 had strong expression of CDK4 and MDM2. Strong expression of CDK4 was found in two additional tumors; one had a gain of 12q13-q21, and the other had no changes in chromosome 12 by CGH. No alterations were detected in the CDK4, MDM2, and SAS panel in three other samples with no changes in chromosome 12 by CGH. In conclusion, the low number of DNA sequence copy number alterations reflects the relatively low malignancy of low-grade central osteosarcoma. This simplicity differs from the complex aberrations seen in conventional high-grade osteosarcomas.

Original languageEnglish
Pages (from-to)421-426
Number of pages6
JournalModern Pathology
Volume11
Issue number5
Publication statusPublished - May 1998

Fingerprint

Comparative Genomic Hybridization
Osteosarcoma
Chromosomes, Human, Pair 12
Neoplasms
DNA Copy Number Variations
Recurrence
Cytogenetics
Molecular Biology

Keywords

  • Comparative genomic hybridization
  • Low-grade central osteosarcoma

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Tarkkanen, M., Böhling, T., Gamberi, G., Ragazzini, P., Benassi, M. S., Kivioja, A., ... Knuutila, S. (1998). Comparative genomic hybridization of low-grade central osteosarcoma. Modern Pathology, 11(5), 421-426.

Comparative genomic hybridization of low-grade central osteosarcoma. / Tarkkanen, M.; Böhling, T.; Gamberi, G.; Ragazzini, P.; Benassi, M. S.; Kivioja, A.; Kallio, P.; Elomaa, I.; Picci, P.; Knuutila, S.

In: Modern Pathology, Vol. 11, No. 5, 05.1998, p. 421-426.

Research output: Contribution to journalArticle

Tarkkanen, M, Böhling, T, Gamberi, G, Ragazzini, P, Benassi, MS, Kivioja, A, Kallio, P, Elomaa, I, Picci, P & Knuutila, S 1998, 'Comparative genomic hybridization of low-grade central osteosarcoma', Modern Pathology, vol. 11, no. 5, pp. 421-426.
Tarkkanen M, Böhling T, Gamberi G, Ragazzini P, Benassi MS, Kivioja A et al. Comparative genomic hybridization of low-grade central osteosarcoma. Modern Pathology. 1998 May;11(5):421-426.
Tarkkanen, M. ; Böhling, T. ; Gamberi, G. ; Ragazzini, P. ; Benassi, M. S. ; Kivioja, A. ; Kallio, P. ; Elomaa, I. ; Picci, P. ; Knuutila, S. / Comparative genomic hybridization of low-grade central osteosarcoma. In: Modern Pathology. 1998 ; Vol. 11, No. 5. pp. 421-426.
@article{8ac7707bce1a4a3fb7f8d036ec6cce53,
title = "Comparative genomic hybridization of low-grade central osteosarcoma",
abstract = "Very little is known concerning the cytogenetic and molecular genetic changes of low-grade central osteosarcoma, a rare form of osteosarcoma. In the present study, we used comparative genomic hybridization (CGH) to screen for DNA sequence copy number aberrations in 10 samples from 6 patients: 7 typical low-grade central osteosarcomas, one low-grade (Grade II) central osteosarcoma, and two high-grade (III and IV) local recurrences of a low- grade central osteosarcoma. Nine samples had aberrations. Six typical low- grade central osteosarcoma samples had a single DNA sequence copy number change per tumor. Three samples from more advanced tumors (a Grade II low- grade central osteosarcoma and local recurrences of Grade III and IV) had a mean of five changes per tumor. Recurrent changes affected these minimal common regions: +12q13-q14 (three tumors), +12p (two tumors), and +6p21.1- p21.3 (two tumors). Nine samples were analyzed for CDK4 and MDM2 expression and SAS amplification. One sample with a gain of chromosome 12 had a very strong expression of MDM2, strong expression of CDK4, and amplification of SAS. One sample with a gain of 12q13-q14 had strong expression of CDK4 and MDM2. Strong expression of CDK4 was found in two additional tumors; one had a gain of 12q13-q21, and the other had no changes in chromosome 12 by CGH. No alterations were detected in the CDK4, MDM2, and SAS panel in three other samples with no changes in chromosome 12 by CGH. In conclusion, the low number of DNA sequence copy number alterations reflects the relatively low malignancy of low-grade central osteosarcoma. This simplicity differs from the complex aberrations seen in conventional high-grade osteosarcomas.",
keywords = "Comparative genomic hybridization, Low-grade central osteosarcoma",
author = "M. Tarkkanen and T. B{\"o}hling and G. Gamberi and P. Ragazzini and Benassi, {M. S.} and A. Kivioja and P. Kallio and I. Elomaa and P. Picci and S. Knuutila",
year = "1998",
month = "5",
language = "English",
volume = "11",
pages = "421--426",
journal = "Modern Pathology",
issn = "0893-3952",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Comparative genomic hybridization of low-grade central osteosarcoma

AU - Tarkkanen, M.

AU - Böhling, T.

AU - Gamberi, G.

AU - Ragazzini, P.

AU - Benassi, M. S.

AU - Kivioja, A.

AU - Kallio, P.

AU - Elomaa, I.

AU - Picci, P.

AU - Knuutila, S.

PY - 1998/5

Y1 - 1998/5

N2 - Very little is known concerning the cytogenetic and molecular genetic changes of low-grade central osteosarcoma, a rare form of osteosarcoma. In the present study, we used comparative genomic hybridization (CGH) to screen for DNA sequence copy number aberrations in 10 samples from 6 patients: 7 typical low-grade central osteosarcomas, one low-grade (Grade II) central osteosarcoma, and two high-grade (III and IV) local recurrences of a low- grade central osteosarcoma. Nine samples had aberrations. Six typical low- grade central osteosarcoma samples had a single DNA sequence copy number change per tumor. Three samples from more advanced tumors (a Grade II low- grade central osteosarcoma and local recurrences of Grade III and IV) had a mean of five changes per tumor. Recurrent changes affected these minimal common regions: +12q13-q14 (three tumors), +12p (two tumors), and +6p21.1- p21.3 (two tumors). Nine samples were analyzed for CDK4 and MDM2 expression and SAS amplification. One sample with a gain of chromosome 12 had a very strong expression of MDM2, strong expression of CDK4, and amplification of SAS. One sample with a gain of 12q13-q14 had strong expression of CDK4 and MDM2. Strong expression of CDK4 was found in two additional tumors; one had a gain of 12q13-q21, and the other had no changes in chromosome 12 by CGH. No alterations were detected in the CDK4, MDM2, and SAS panel in three other samples with no changes in chromosome 12 by CGH. In conclusion, the low number of DNA sequence copy number alterations reflects the relatively low malignancy of low-grade central osteosarcoma. This simplicity differs from the complex aberrations seen in conventional high-grade osteosarcomas.

AB - Very little is known concerning the cytogenetic and molecular genetic changes of low-grade central osteosarcoma, a rare form of osteosarcoma. In the present study, we used comparative genomic hybridization (CGH) to screen for DNA sequence copy number aberrations in 10 samples from 6 patients: 7 typical low-grade central osteosarcomas, one low-grade (Grade II) central osteosarcoma, and two high-grade (III and IV) local recurrences of a low- grade central osteosarcoma. Nine samples had aberrations. Six typical low- grade central osteosarcoma samples had a single DNA sequence copy number change per tumor. Three samples from more advanced tumors (a Grade II low- grade central osteosarcoma and local recurrences of Grade III and IV) had a mean of five changes per tumor. Recurrent changes affected these minimal common regions: +12q13-q14 (three tumors), +12p (two tumors), and +6p21.1- p21.3 (two tumors). Nine samples were analyzed for CDK4 and MDM2 expression and SAS amplification. One sample with a gain of chromosome 12 had a very strong expression of MDM2, strong expression of CDK4, and amplification of SAS. One sample with a gain of 12q13-q14 had strong expression of CDK4 and MDM2. Strong expression of CDK4 was found in two additional tumors; one had a gain of 12q13-q21, and the other had no changes in chromosome 12 by CGH. No alterations were detected in the CDK4, MDM2, and SAS panel in three other samples with no changes in chromosome 12 by CGH. In conclusion, the low number of DNA sequence copy number alterations reflects the relatively low malignancy of low-grade central osteosarcoma. This simplicity differs from the complex aberrations seen in conventional high-grade osteosarcomas.

KW - Comparative genomic hybridization

KW - Low-grade central osteosarcoma

UR - http://www.scopus.com/inward/record.url?scp=0344973662&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0344973662&partnerID=8YFLogxK

M3 - Article

VL - 11

SP - 421

EP - 426

JO - Modern Pathology

JF - Modern Pathology

SN - 0893-3952

IS - 5

ER -